Adial Pharmaceuticals, Inc. (ADIL)
NASDAQ: ADIL · Real-Time Price · USD
2.450
-0.110 (-4.30%)
Feb 20, 2026, 4:00 PM EST - Market closed
Adial Pharmaceuticals Market Cap
Adial Pharmaceuticals has a market cap or net worth of $2.72 million as of February 20, 2026. Its market cap has decreased by -48.62% in one year.
Market Cap
2.72M
Enterprise Value
-1.88M
1-Year Change
-48.62%
Ranking
Category
Stock Price
$2.45
Market Cap Chart
Since July 30, 2018, Adial Pharmaceuticals's market cap has decreased from $26.33M to $2.72M, a decrease of -89.66%. That is a compound annual growth rate of -25.91%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Feb 20, 2026 | 2.72M | -53.57% |
| Dec 31, 2025 | 5.86M | -10.34% |
| Dec 31, 2024 | 6.54M | 188.66% |
| Dec 29, 2023 | 2.27M | -60.76% |
| Dec 30, 2022 | 5.77M | -89.79% |
| Dec 31, 2021 | 56.55M | 131.15% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Jul 30, 2018 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| GeoVax Labs | 3.49M |
| Enveric Biosciences | 3.28M |
| HCW Biologics | 3.21M |
| Oragenics | 2.86M |
| Propanc Biopharma | 2.83M |
| SciSparc | 2.78M |
| XORTX Therapeutics | 2.70M |
| Psyence Biomedical | 2.65M |